Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-17
2008-10-28
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07442715
ABSTRACT:
A compound of the formula (I): R1—NH—X—Y-Z (I) wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof useful as a vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, a method for preventing or treating a VAP-1 associated disease, especially macular edema, which method includes administering an effective amount of the compound or a pharmaceutically acceptable salt thereof to a mammal, and the like.
REFERENCES:
patent: 4888283 (1989-12-01), Bertini et al.
patent: 7125901 (2006-10-01), Inoue et al.
patent: 2002/0173521 (2002-11-01), Smith, et al.
patent: 2006/0128770 (2006-06-01), Inoue, et al.
patent: 2006/0229346 (2006-10-01), Ueno, et al.
patent: 2006/0276521 (2006-12-01), Inoue, et al.
patent: 61-239891 (1986-10-01), None
patent: WO 93/23023 (1993-11-01), None
patent: 9630350 (1996-10-01), None
patent: WO 02/02090 (2002-01-01), None
patent: WO 02/02541 (2002-01-01), None
patent: WO 02/38152 (2002-05-01), None
patent: WO 02/38153 (2002-05-01), None
U.S. Appl. No. 60/517,377, filed Nov. 06, 2003, Inoue, et al.
U.S. Appl. No. 60/458,369, filed Mar. 31, 2003, Inoue, et al.
U.S. Appl. No. 60/442,509, filed Jan. 27, 2003, Nagashima, et al.
U.S. Appl. No. 11/505,321, filed Aug. 17, 2006, Inoue, et al.
F. Boomsma, et al., Diabetologia, vol. 42, pp. 233-237, “Circulating Semicarbazide-Sensitive Amine Oxidase is Raised Both in Type I (Insulin-Dependent). in Type II (Non-Insulin-Dependent) Diabetes Mellitus and Even in Childhood Type I Diabetes at First Clinical Diagnosis”, 1999.
H. Garpenstrand, et al., Diabetic Medicine, vol. 16, pp. 514-521, “Elevated Plasma Semicarbazide-Sensitive Amine Oxidase (SSAO) Activity in Type 2 Diabetes Mellitus Complicated by Retinopathy”, 1999.
Inoue Takayuki
Morita Masataka
Nagashima Akira
Ohkubo Mitsuru
Tojo Takashi
Astellas Pharma Inc.
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
Solola Taofiq A
LandOfFree
Thiazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3994832